Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0276640 (TEM)
 20,729 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Tiopronin (N-(2-mercaptopropionyl)glycine)-protected gold nanoparticles (TPAu) were cross-linked to collagen via EDC (1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide) coupling. On average, each TPAu forms eight amide bonds with collagen lysine moieties. The resulting gels were studied with environmental SEM, TEM, micro-DSC, and TNBS assay. The porous structure of collagen was significantly altered by cross-linking, resulting in the reduction of the pore size from ca. 140 to <1 microm depending on the concentration of nanoparticles. The collagenase biodegradation assay showed improved stability of cross-linked material. The cell viability assay, CellTiter96, indicates that the gold nanoparticles are not toxic at the concentrations used in gel synthesis. This new material has potential for the delivery of small molecule drugs as well as Au nanoparticles for photothermal therapies, imaging, and cell targeting.
 ...
PMID:Collagen cross-linking with Au nanoparticles. 1895 40

Tiopronin-protected silver nanoparticles (average diameter = 5 nm) were partially displaced by (2-mercapto-propionylamino) acetic acid 2,5-dioxo-pyrrolidin-1-ylesters via ligand exchange, and the succinimide-terminated silver particles were bound to amine-labeled Dextran 3000 (1 amine/per chain) or Dextran 10 000 (2.5 amine/per chain), respectively. The particle-Dextran 10 000 adducts were self-aggregated by interactions of multiple amines on Dextran and multi-functionalized ligands on the particle. The transverse plasmon band was blue shifted while the longitudinal plasmon at 575 nm increased, corresponding to the compact aggregation of particles. The particle-Dextran 3000 adducts, which were not aggregated, were coupled to Concanavalin A (Con A) to facilitate the aggregation of particles. The aggregated particles displayed an absorbance spectral change depending on the mole ratio of Con A/particle-Dextran 3000. The particle-Dextran 3000 adduct was released by a competitive complexation of glucose. This process was monitored by both the change in plasmon absorbance and wavelength, with the glucose concentration. The aggregation and dissociation of Con A/particle-Dextran complexes were also verified by TEM images.
 ...
PMID:Aggregation of Silver Nanoparticle-Dextran Adducts with Concanavalin A and Competitive Complexation with Glucose. 3189 53